UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934


August 5, 2020


Date of Report (Date of earliest event reported)



NU SKIN ENTERPRISES, INC.


(Exact name of registrant as specified in its charter)


Delaware

001-12421

87-0565309
(State or other jurisdiction of incorporation)

(Commission File Number)

(IRS Employer Identification Number)


75 West Center Street
Provo, Utah 84601


(Address of principal executive offices and zip code)



(801) 345-1000


(Registrant’s telephone number, including area code)



N/A


(Former name or former address, if changed since last report)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4 (c))
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Class A Common Stock, $.001 par value
NUS
New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.



Item 2.02
Results of Operations and Financial Condition.

On August 5, 2020, Nu Skin Enterprises, Inc. (the “Company”) issued a press release announcing its financial results for the three- and six-month periods ended June 30, 2020, and certain other information. A copy of the press release is attached as Exhibit 99.1 to this report.

The information furnished pursuant to this Item 2.02 and the exhibit hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and shall not be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act except as shall be expressly set forth by specific reference in such filing.

The press release furnished herewith in Exhibit 99.1 contains non-GAAP financial measures. Management believes non-GAAP financial measures assist management and investors in evaluating and comparing period-to-period results and projections in a more meaningful and consistent manner.

Item 9.01
Financial Statements and Exhibits.

(d) Exhibits.

Nu Skin Enterprises’ press release dated August 5, 2020, regarding financial results for the three- and six-month periods ended June 30, 2020.


104
Cover Page Interactive Data File (embedded within the Inline XBRL document)


SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 

NU SKIN ENTERPRISES, INC.

(Registrant)



/s/ Mark H. Lawrence


Mark H. Lawrence

Chief Financial Officer


Date:  August 5, 2020





Exhibit 99.1


FOR IMMEDIATE RELEASE

NU SKIN ENTERPRISES REPORTS SECOND-QUARTER 2020 RESULTS
AND RAISES 2020 GUIDANCE

PROVO, Utah — Aug. 5, 2020 — Nu Skin Enterprises, Inc. (NYSE: NUS) today announced second-quarter results above expectations and raised its revenue and earnings per share guidance for 2020.

Executive Summary
Q2 2020 vs. Prior-Year Quarter

Revenue:
   
$612.4 million; (2%)
    (3%) fx impact or ($19.8) million
Earnings Per Share (EPS):
   
$0.81; (2%)
Sales Leaders:
   
56,036; (9%)
Customers:
   
1,499,900; +29%

“Our business performed well above expectations in the second quarter of 2020 driven by our socially enabled business model, strategic investments in technology and manufacturing, and our balanced product portfolio,” said Ritch Wood, chief executive officer. “Strong global customer growth of 29 percent in the quarter, driven by our focus on empowering sales leaders to reach more customers, resulted in constant currency revenue growth due to the strength of our business in the Americas and Europe. Our Mainland China business continues to recover with slight sequential revenue improvement and strong customer growth.

“I am particularly proud of the way our global sales leaders have embraced socially enabled commerce, with more than 85 percent of revenue in the quarter coming through digital transactions. In addition, our manufacturing division generated 20 percent revenue growth and increased stability in our supply chain. In the first half, we generated strong cash from operations, raised our dividend, strengthened our balance sheet and reduced our outstanding shares by nearly eight percent.”

- more -

Nu Skin Enterprises Reports Second-quarter 2020 Results, Raises Guidance
 Page 2 
Q2 2020 Year-Over-Year Operating Results

Revenue:
   
$612.4 million compared to $623.5 million
     (3%) fx impact or ($19.8) million
Gross Margin:
   
74.8% compared to 75.3%
     Nu Skin business was 77.6% compared to 77.8%
Selling Expenses:
   
40.6% compared to 39.4%
     Nu Skin business was 43.3% compared to 41.5%
G&A Expenses:
   
24.7% compared to 24.0%
Operating Margin:
   
9.5% compared to 11.9%
Other Income / (Expense):
   
$1.6 million compared to ($3.3) million
Income Tax Rate:
   
29.8% compared to 34.6%
EPS:
   
$0.81 compared to $0.83

Stockholder Value

Dividend Payments:
   
$19.4 million
Stock Repurchases:
   
$46.5 million
     $362.8 million remaining in authorization

Q3 and Full-Year 2020 Outlook

Q3 2020 Revenue:
   
$605 to $635 million; +3 to 8%
     Approximately (1 to 2%) fx impact
Q3 2020 EPS:
   
$0.78 to $0.88
2020 Revenue:
   
$2.37 to $2.45 billion; (2%) to +1%
     Approximately (2 to 3%) fx impact
2020 EPS
   
$2.85 to $3.10

“Our performance so far this year gives us confidence for the second half and momentum as we move into 2021. We believe the improved productivity of our sales leaders is driving strong customer growth and will lead to sales force expansion as we move toward the introduction of our ageLOC Boost device and Nutricentials Bioadaptive Skin Care in the second half. We will continue to focus on the expansion of our socially enabled business around the world with the release of our latest digital tool, Vera, a personal product recommendation app. Overall, we are confident in the direction of our strategy and the future ahead,” Wood concluded.

- more -


Nu Skin Enterprises Reports Second-quarter 2020 Results, Raises Guidance
 Page 3 
Mark Lawrence, chief financial officer, added, “We delivered results above expectations and achieved constant currency revenue growth ahead of schedule. Given our performance in the first half and continued trends in our customer and sales leader pipeline, we are raising our guidance for the year. As we look ahead to the third quarter, we anticipate revenue of $605 to $635 million, which includes 1 to 2 percent unfavorable foreign currency impact, and earnings per share of $0.78 to $0.88. We are raising our 2020 revenue guidance to $2.37 to $2.45 billion, which reflects a negative foreign currency impact of 2 to 3 percent, and we anticipate annual earnings per share of $2.85 to $3.10.”
 
Conference Call
The Nu Skin Enterprises management team will host a conference call with the investment community today at 5 p.m. (ET). Those wishing to access the webcast, as well as the financial information presented during the call, can visit the Investor Relations page on the company’s website at ir.nuskin.com. A replay of the webcast will be available at the same URL through Aug. 19, 2020.
 
About Nu Skin Enterprises, Inc.
Founded more than 35 years ago, Nu Skin Enterprises, Inc. (NSE) empowers innovative companies to change the world with sustainable solutions, opportunities, technologies and life-improving values. The company currently focuses its efforts around innovative consumer products, product manufacturing and controlled environment agriculture technology. The NSE family of companies includes Nu Skin, which develops and distributes a comprehensive line of premium-quality beauty and wellness solutions through a global network of sales leaders in Asia, the Americas, Europe, Africa and the Pacific; and Rhyz, our strategic investment arm that includes a collection of sustainable manufacturing and technology innovation companies. Nu Skin Enterprises is traded on the New York Stock Exchange under the symbol "NUS." More information is available at nuskinenterprises.com.
 
Important Information Regarding Forward-Looking Statements: This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that represent the company’s current expectations and beliefs. All statements other than statements of historical fact are “forward-looking statements” for purposes of federal and state securities laws and include, but are not limited to, statements of management’s expectations regarding the company’s performance, growth, product launches, customers and sales leaders, benefits to shareholders, strategies and initiatives; statements of management’s expectations regarding the future status of the COVID-19 pandemic globally and across the company’s markets, and government and public behavior in response to such status; projections regarding revenue, earnings per share, foreign currency fluctuations and other financial items; statements of belief; and statements of assumptions underlying any of the foregoing. In some cases, you can identify these statements by forward-looking words such as “believe,” “expect,” “continue,” “anticipate,” “project,” “outlook,” “guidance,” “plan,” “continue,” “will,” “would,” “could,” “may,” “might,” the negative of these words and other similar words.

- more -


Nu Skin Enterprises Reports Second-quarter 2020 Results, Raises Guidance
 Page 4 
The forward-looking statements and related assumptions involve risks and uncertainties that could cause actual results and outcomes to differ materially from any forward-looking statements or views expressed herein. These risks and uncertainties include, but are not limited to, the following:

risk that epidemics, including the ongoing COVID-19 outbreak, and other crises could negatively impact our business;

adverse publicity related to the company’s business, products, industry or any legal actions or complaints by the company’s sales force or others;

risk that direct selling laws and regulations in any of the company’s markets, including the United States and Mainland China, may be modified, interpreted or enforced in a manner that results in negative changes to the company’s business model or negatively impacts its revenue, sales force or business, including through the interruption of sales activities, loss of licenses, imposition of fines, or any other adverse actions or events;

any failure of current or planned initiatives or products to generate interest among the company’s sales force and customers and generate sponsoring and selling activities on a sustained basis;

political, legal, tax and regulatory uncertainties associated with operating in international markets, including Mainland China;

uncertainty regarding meeting restrictions and other government scrutiny in Mainland China, as well as negative media and consumer sentiment in Mainland China on our business operations and results;

risk of foreign-currency fluctuations and the currency translation impact on the company’s business associated with these fluctuations;

uncertainties regarding the future financial performance of the businesses the company has acquired;

risks related to accurately predicting, delivering or maintaining sufficient quantities of products to support planned initiatives or launch strategies, and increased risk of inventory write-offs if the company over-forecasts demand for a product or changes its planned initiatives or launch strategies;

regulatory risks associated with the company’s products, which could require the company to modify its claims or inhibit its ability to import or continue selling a product in a market if the product is determined to be a medical device or if the company is unable to register the product in a timely manner under applicable regulatory requirements;

unpredictable economic conditions and events globally, including trade policies and tariffs;

uncertainties related to interpretation of, and forthcoming regulations under, the recently enacted U.S. tax reform legislation; the company’s future tax-planning initiatives; any prospective or retrospective increases in duties on the company’s products imported into the company’s markets outside of the United States; and any adverse results of tax audits or unfavorable changes to tax laws in the company’s various markets; and

continued competitive pressures in the company’s markets.
 
 The company’s financial performance and the forward-looking statements contained herein are further qualified by a detailed discussion of associated risks set forth in the documents filed by the company with the Securities and Exchange Commission. The forward-looking statements set forth the company’s beliefs as of the date that such information was first provided, and the company assumes no duty to update the forward-looking statements contained in this release to reflect any change except as required by law.

Non-GAAP Financial Measures: Constant-currency revenue change is a non-GAAP financial measure that removes the impact of fluctuations in foreign-currency exchange rates, thereby facilitating period-to-period comparisons of the company’s performance. It is calculated by translating the current period’s revenue at the same average exchange rates in effect during the applicable prior-year period and then comparing that amount to the prior-year period’s revenue. The company believes that constant-currency revenue change is useful to investors, lenders and analysts because such information enables them to gauge the impact of foreign-currency fluctuations on the company’s revenue from period to period.

- more -


Nu Skin Enterprises Reports Second-quarter 2020 Results, Raises Guidance
 Page 5 
The following table sets forth revenue for the three-month periods ended June 30, 2020 and 2019 for each of our reportable segments (U.S. dollars in thousands):

   
Three Months Ended
June 30,
         
Constant-
Currency
 
   
2020
   
2019
   
Change
   
Change
 
Nu Skin
                       
Mainland China
 
$
146,332
   
$
185,333
     
(21
%)
   
(18
%)
Americas/Pacific
   
127,919
     
92,841
     
38
%
   
48
%
South Korea
   
76,915
     
84,732
     
(9
%)
   
(5
%)
Southeast Asia
   
66,829
     
75,395
     
(11
%)
   
(9
%)
Japan
   
68,291
     
65,251
     
5
%
   
2
%
EMEA
   
50,776
     
43,400
     
17
%
   
21
%
Hong Kong/Taiwan
   
37,161
     
43,712
     
(15
%)
   
(17
%)
Other
   
(85
)
   
1,249
     
(107
%)
   
(107
%)
Total Nu Skin
   
574,138
     
591,913
     
(3
%)
   
 
Manufacturing
   
37,918
     
31,557
     
20
%
   
20
%
Grow Tech
   
310
     
30
     
933
%
   
933
%
Total
 
$
612,366
   
$
623,500
     
(2
%)
   
1
%

The following table sets forth revenue for the six-month periods ended June 30, 2020 and 2019 for each of our reportable segments (U.S. dollars in thousands):

   
Six Months Ended
June 30,
         
Constant-
Currency
 
   
2020
   
2019
   
Change
   
Change
 
Nu Skin
                       
Mainland China
 
$
284,028
   
$
393,821
     
(28
%)
   
(25
%)
Americas/Pacific
   
202,492
     
179,297
     
13
%
   
21
%
South Korea
   
152,634
     
168,585
     
(9
%)
   
(5
%)
Southeast Asia
   
136,415
     
147,890
     
(8
%)
   
(6
%)
Japan
   
129,591
     
127,360
     
2
%
   
 
EMEA
   
86,179
     
85,218
     
1
%
   
4
%
Hong Kong/Taiwan
   
72,988
     
84,270
     
(13
%)
   
(15
%)
Other
   
688
     
(177
)
   
(489
%)
   
(488
%)
Total Nu Skin
   
1,065,015
     
1,186,264
     
(10
%)
   
(7
%)
Manufacturing
   
65,065
     
60,829
     
7
%
   
7
%
Grow Tech
   
314
     
30
     
947
%
   
947
%
Total
 
$
1,130,394
   
$
1,247,123
     
(9
%)
   
(7
%)

- more -


Nu Skin Enterprises Reports Second-quarter 2020 Results, Raises Guidance
 Page 6 
The company's Customers and Sales Leaders statistics by segment as of June 30, 2020 and 2019 are presented in the following table:

   
As of
June 30, 2020
   
As of
June 30, 2019
   
% Increase (Decrease)
 
   
Customers
   
Sales
Leaders
   
Customers
   
Sales
Leaders
   
Customers
   
Sales
Leaders
 
                                     
Mainland China
   
321,946
     
17,104
     
226,877
     
24,336
     
42
%
   
(30
%)
Americas/Pacific
   
424,236
     
10,787
     
253,684
     
8,161
     
67
%
   
32
%
South Korea
   
159,926
     
6,881
     
180,365
     
7,239
     
(11
%)
   
(5
%)
Southeast Asia
   
155,822
     
6,790
     
137,450
     
7,417
     
13
%
   
(8
%)
Japan
   
125,332
     
6,011
     
127,900
     
5,931
     
(2
%)
   
1
%
EMEA
   
247,057
     
5,120
     
164,055
     
4,256
     
51
%
   
20
%
Hong Kong/Taiwan
   
65,581
     
3,343
     
70,089
     
4,223
     
(6
%)
   
(21
%)
Total
   
1,499,900
     
56,036
     
1,160,420
     
61,563
     
29
%
   
(9
%)

“Customers” are persons who purchased products directly from the company during the previous three months. Our Customer numbers do not include consumers who purchase products directly from members of our sales force.

“Sales Leaders” are independent distributors, and sales employees and independent marketers in China, who achieve certain qualification requirements.

- more -


Nu Skin Enterprises Reports Second-quarter 2020 Results, Raises Guidance
 Page 7 
NU SKIN ENTERPRISES, INC.
Consolidated Statements of Income (Unaudited)
(U.S. dollars in thousands, except per share amounts)

   
Three Months Ended
June 30,
   
Six Months Ended
June 30,
 
   
2020
   
2019
   
2020
   
2019
 
                         
Revenue
 
$
612,366
   
$
623,500
   
$
1,130,394
   
$
1,247,123
 
Cost of sales
   
154,110
     
154,028
     
279,903
     
300,692
 
Gross profit
   
458,256
     
469,472
     
850,491
     
946,431
 
                                 
Operating expenses:
                               
Selling expenses
   
248,628
     
245,828
     
454,670
     
495,536
 
General and administrative expenses
   
151,554
     
149,442
     
301,182
     
308,040
 
Total operating expenses
   
400,182
     
395,270
     
755,852
     
803,576
 
                                 
Operating income
   
58,074
     
74,202
     
94,639
     
142,855
 
Other income (expense), net
   
1,581
     
(3,326
)
   
(4,593
)
   
(6,174
)
                                 
Income before provision for income taxes
   
59,655
     
70,876
     
90,046
     
136,681
 
Provision for income taxes
   
17,804
     
24,527
     
28,465
     
47,330
 
                                 
Net income
 
$
41,851
   
$
46,349
   
$
61,581
   
$
89,351
 
                                 
Net income per share:
                               
Basic
 
$
0.81
   
$
0.83
   
$
1.15
   
$
1.61
 
Diluted
 
$
0.81
   
$
0.83
   
$
1.15
   
$
1.59
 
                                 
Weighted-average common shares outstanding (000s):
                               
Basic
   
51,872
     
55,536
     
53,466
     
55,486
 
Diluted
   
51,925
     
55,943
     
53,502
     
56,030
 

- more -


Nu Skin Enterprises Reports Second-quarter 2020 Results, Raises Guidance
 Page 8 
NU SKIN ENTERPRISES, INC.
Consolidated Balance Sheets (Unaudited)
(U.S. dollars in thousands)

   
June 30,
2020
   
December 31,
2019
 
ASSETS
           
Current assets:
           
Cash and cash equivalents
 
$
375,512
   
$
335,630
 
Current investments
   
10,788
     
8,413
 
Accounts receivable, net
   
64,371
     
50,378
 
Inventories, net
   
261,969
     
275,891
 
Prepaid expenses and other
   
73,200
     
69,854
 
Total current assets
   
785,840
     
740,166
 
                 
Property and equipment, net
   
444,848
     
453,604
 
Right-of-use assets
   
142,700
     
144,326
 
Goodwill
   
196,573
     
196,573
 
Other intangible assets, net
   
76,161
     
80,321
 
Other assets
   
148,371
     
154,016
 
Total assets
 
$
1,794,493
   
$
1,769,006
 
                 
LIABILITIES AND STOCKHOLDERS’ EQUITY
               
Current liabilities:
               
Accounts payable
 
$
51,655
   
$
38,979
 
Accrued expenses
   
337,980
     
290,281
 
Current portion of long-term debt
   
95,000
     
27,500
 
Total current liabilities
   
484,635
     
356,760
 
                 
Operating lease liabilities
   
103,043
     
105,701
 
Long-term debt
   
319,932
     
334,461
 
Other liabilities
   
94,871
     
96,795
 
Total liabilities
   
1,002,481
     
893,717
 
                 
Stockholders’ equity:
               
Class A common stock
   
91
     
91
 
Additional paid-in capital
   
563,115
     
557,544
 
Treasury stock, at cost
   
(1,427,064
)
   
(1,324,826
)
Accumulated other comprehensive loss
   
(93,441
)
   
(85,292
)
Retained earnings
   
1,749,311
     
1,727,772
 
Total stockholders' equity
   
792,012
     
875,289
 
Total liabilities and stockholders’ equity
 
$
1,794,493
   
$
1,769,006
 

# # #
 
CONTACTS:
Media: media@nuskin.com, (801) 345-6397
Investors: investorrelations@nuskin.com, (801) 345-3577